‘The world we know is over’ without urgent climate action, Marshall Islands president tells Cop31
Published . Updated .
Market Call
Think this story will push the stock up or down over the next three trading days? Make a free call and see what other readers think. Points are play money with no cash value.
Get these market calls by email
The week's biggest market-moving stories, Congress trades and Trump posts, with the tickers they touch. Free, one email a week.
Free. We only use your email to send the digest, never sell or share it, and every email has a one-click unsubscribe link. See our privacy policy.
Hilda Heine warns of effects of catastrophic global heating as world leaders meet in Turkey amid calls for urgent action on fossil fuels Cop31 live – latest updates Failure to provide an overwhelming response to the climate crisis means “the world we know is over”, the president of the embattled Marshall Islands has warned, as dozens of leaders gathered in Turkey for the Cop31 climate summit. Hilda Heine, one of a handful of Pacific Island leaders to make an impassioned speech at Cop31 on Wednesday, told other heads of state that overshooting the 1.5C Paris temperature target would mean waves eating away their shores and floods that destroy towns, schools and hospitals. Continue reading...
Directly affected
- No company is named in this report.
Indirectly affected
- XLV Health Care Select Sector SPDR
Health Care Select Sector SPDR: it holds drugmakers and health companies. Linked by “hospital” (pharma and health) in this story.
- XBI SPDR S&P Biotech ETF
SPDR S&P Biotech ETF: it holds drugmakers and health companies. Linked by “hospital” (pharma and health) in this story.
- EWQ iShares MSCI France ETF-0.5% 6d
iShares MSCI France ETF holds stocks listed in France, which this story is about (“paris”).
- TUR iShares MSCI Turkey ETF-17.0% 30d
iShares MSCI Turkey ETF holds stocks listed in Turkey, which this story is about (“turkey”).
- LLY Eli Lilly and+25.0% 30d
Eli Lilly and (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “hospital” (pharma and health) in this story.
- JNJ Johnson & Johnson+9.5% 30d
Johnson & Johnson (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “hospital” (pharma and health) in this story.
- PFE Pfizer+6.0% 30d
Pfizer (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “hospital” (pharma and health) in this story.
- MRK Merck+3.7% 30d
Merck (pharmaceutical preparations): drugmakers move with drug pricing, approvals and health policy. Linked by “hospital” (pharma and health) in this story.
Price reaction, T-5 to T+3
| Ticker | T-5 | T-3 | T-1 | T0 | T+1 | T+2 | T+3 |
|---|---|---|---|---|---|---|---|
| XLV | +0.42% | -2.16% | base | +0.02% | -0.38% | after close | after close |
| XBI | +2.62% | -1.83% | base | +0.78% | -2.49% | after close | after close |
| EWQ | -0.57% | -2.72% | base | -0.42% | -0.69% | after close | after close |
| TUR | -0.63% | -1.67% | base | +0.54% | +0.72% | after close | after close |
| LLY | -1.00% | -5.42% | base | +0.38% | -0.16% | after close | after close |
| JNJ | -1.58% | -1.58% | base | -0.16% | +0.99% | after close | after close |
| PFE | +4.87% | +0.09% | base | +0.31% | -1.81% | after close | after close |
| MRK | +1.60% | -0.83% | base | -0.53% | -0.70% | after close | after close |
Closing-price change versus T-1, the last close before the story. T0 to T+3 fill in after each market close. Prices: Alpaca IEX.
Hilda Heine warns of effects of catastrophic global heating as world leaders meet in Turkey amid calls for urgent action on fossil fuels Cop31 live – latest updates Failure to provide an overwhelming response to the climate crisis means “t…
Source: The Guardian
This story
| Company | When | Move | Status |
|---|---|---|---|
| EWQ | that day | -0.42% | final price |
| EWQ | the next day | -0.69% | final price |
| EWQ | three days earlier | -2.72% | final price |
| EWQ | five days earlier | -0.57% | final price |
| JNJ | that day | -0.16% | final price |
| JNJ | the next day | +0.99% | final price |
| JNJ | three days earlier | -1.58% | final price |
| JNJ | five days earlier | -1.58% | final price |
| LLY | that day | +0.38% | final price |
| LLY | the next day | -0.16% | final price |
| LLY | three days earlier | -5.42% | final price |
| LLY | five days earlier | -1.00% | final price |
| MRK | that day | -0.53% | final price |
| MRK | the next day | -0.70% | final price |
| MRK | three days earlier | -0.83% | final price |
| MRK | five days earlier | +1.60% | final price |
| PFE | that day | +0.31% | final price |
| PFE | the next day | -1.81% | final price |
| PFE | three days earlier | +0.09% | final price |
| PFE | five days earlier | +4.87% | final price |
| TUR | that day | +0.54% | final price |
| TUR | the next day | +0.72% | final price |
| TUR | three days earlier | -1.67% | final price |
| TUR | five days earlier | -0.63% | final price |
| XBI | that day | +0.78% | final price |
| XBI | the next day | -2.49% | final price |
| XBI | three days earlier | -1.83% | final price |
| XBI | five days earlier | +2.62% | final price |
| XLV | that day | +0.02% | final price |
| XLV | the next day | -0.38% | final price |
| XLV | three days earlier | -2.16% | final price |
| XLV | five days earlier | +0.42% | final price |
Trades by members of Congress and officials in the stocks in this story
- Rep. Rohit Khanna bought Eli Lilly (LLY) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 68 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Johnson & Johnson (JNJ) (held by a spouse), worth $15,001 - $50,000 on 7 Oct 2026. That is 35 days before publication. Filed 5 Nov 2026. View the filing.
- Rep. Thomas H. Kean Jr sold Johnson & Johnson (JNJ), worth $1,001 - $15,000 on 30 Sep 2026. That is 42 days before publication. Filed 30 Oct 2026. View the filing.
- Rep. Rohit Khanna bought Johnson & Johnson (JNJ) (held by a spouse), worth $1,001 - $15,000 on 25 Sep 2026. That is 47 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Rohit Khanna sold Pfizer (PFE) (held by a spouse), worth $1,001 - $15,000 on 4 Sep 2026. That is 68 days before publication. Filed 7 Oct 2026. View the filing.
- Donald J Trump, an executive branch official, bought Pfizer (PFE), worth $100,001 - $250,000 on 21 Aug 2026. That is 82 days before publication. Filed 8 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar sold Merck (MRK), worth $1,001 - $15,000 on 24 Sep 2026. That is 48 days before publication. Filed 7 Oct 2026. View the filing.
- Rep. Maria Elvira Salazar bought Merck (MRK), worth $15,001 - $50,000 on 19 Aug 2026. That is 84 days before publication. Filed 9 Sep 2026. View the filing.
Public disclosure filings, not a recommendation. The filing link is the source document. News use of these reports still sits under 5 U.S.C. § 13107(c).
This story
12 out of 100
“‘The world we know is over’ without urgent climate action, Marshall Islands president tells Cop31” scores 12 out of 100. The score uses 1 sources.